20.47
0.00
(0.00%)
At close: January 13 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
7,978,000.00
5,117,000.00
7,093,000.00
5,089,000.00
4,903,000.00
Investing Cash Flow
-2,426,000.00
-3,517,000.00
-2,381,000.00
855,000.00
-4,073,000.00
Financing Cash Flow
-7,522,000.00
-679,000.00
-4,220,000.00
-5,645,000.00
423,000.00
End Cash Position
4,845,000.00
5,907,000.00
5,171,000.00
4,564,000.00
4,191,000.00
Capital Expenditure
-2,675,000.00
-2,751,000.00
-2,949,000.00
-2,611,000.00
-2,418,000.00
Issuance of Capital Stock
--
23,000.00
15,000.00
--
--
Issuance of Debt
10,724,000.00
16,284,000.00
6,631,000.00
6,592,000.00
10,891,000.00
Repayment of Debt
-16,214,000.00
-13,031,000.00
-7,605,000.00
-9,044,000.00
-6,424,000.00
Free Cash Flow
5,303,000.00
2,366,000.00
4,144,000.00
2,478,000.00
2,485,000.00
12/31/2020 - 2/13/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CMOPF Cosmo Pharmaceuticals N.V.
66.93
0.00%
JNJd.XC
GILD34.SA Gilead Sciences, Inc.
274.00
+0.37%
600436.SS PIENTZEHUANG
209.16
+2.03%
SNW.F Sanofi
94.96
-0.15%
SNW.HM Sanofi SA
95.03
-0.20%
CHGCY Chugai Pharmaceutical Co., Ltd.
21.08
-0.38%
BIIB34.SA Biogen Inc.
151.21
-0.59%
GS71.DE GSK plc
15.72
-1.47%
COPNz.XC